Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Koninklijke Philips (NYSE:PHG) Rebounds Modestly Today Despite Cautious Analyst Sentiment

Koninklijke Philips (NYSE:PHG) shares are rebounding modestly in Tuesday trading, up about 1.8 percent intraday, as investors digest the aftermath of Monday's post-earnings selloff that sent the stock to a 52-week low near $23.86. While second-quarter results beat estimates on both revenue and earnings …

Nitish Kishor | 28 July 2026

Cigna Corporation (NYSE:CI) Rises Sharply Today Amid Sector-Wide Managed Care Rally

Cigna Corporation (NYSE:CI) shares rose sharply in Tuesday trading, tracking a sector-wide rally in managed care after Centene (NYSE:CNC) raised its 2026 profit guidance and posted a much-improved medical loss ratio, easing investor fears about elevated medical costs across the industry.

Nitish Kishor | 28 July 2026

DaVita (NYSE:DVA) Climbs Toward 52-Week High Today Alongside Broader Healthcare Strength

DaVita (NYSE:DVA) shares climbed alongside broader healthcare sector strength in Tuesday trading, pushing the stock near its 52-week high as investors rotated into defensive names amid a mixed macro backdrop. Warren Buffett's Berkshire Hathaway (NYSE:BRK.B), the dialysis provider's largest shareholder at roughly 45 percent …

Nitish Kishor | 28 July 2026

EUDA Health Holdings (NASDAQ:EUDA) Rises Today on New Cell Therapy Collaboration

EUDA Health Holdings (NASDAQ:EUDA) shares rose in Tuesday trading after the company announced it had signed a memorandum of understanding with GO POSB Organoids and Shenzhen Innovation Immunotechnology to establish a tri-party collaboration on next-generation therapies derived from induced pluripotent stem cells.

Nitish Kishor | 28 July 2026

HCA Healthcare (NYSE:HCA) Surges 5% Today as Analysts Defend Margin Story

HCA Healthcare (NYSE:HCA) shares surged in Tuesday trading as investors continued to digest last Friday's second-quarter results, which beat estimates on both revenue and adjusted earnings per share. Revenue of $20.23 billion rose 8.7 percent year-over-year, while adjusted earnings per share of $7.59 also …

Nitish Kishor | 28 July 2026

Hims & Hers Health (NYSE:HIMS) Falls 6% Today Despite Bullish Long-Term Price Targets

Hims & Hers Health (NYSE:HIMS) shares are declining sharply in Tuesday trading, extending a rough stretch that has seen the stock fall roughly 15 percent over the past week, as investors digest lingering uncertainty from an FDA advisory committee's recent vote on compounded peptides, …

Nitish Kishor | 28 July 2026

Labcorp Holdings (NYSE:LH) Rallies Near 52-Week Highs Today on New Genetic Testing Launch

Labcorp Holdings (NYSE:LH) shares rallied to near 52-week highs in Tuesday trading, extending a multi-week uptrend as investors respond to sustained analyst optimism ahead of upcoming quarterly results and continued momentum from new diagnostic launches.

Nitish Kishor | 28 July 2026

Mobile-health Network Solutions (NASDAQ:MNDR) Falls Today Despite New Ghana Joint Venture

Mobile-health Network Solutions (NASDAQ:MNDR) shares fell in Tuesday trading even after the company announced a definitive joint venture agreement with Jospong Group of Companies, a diversified Ghanaian conglomerate, to establish MHNS Ghana Limited, a vehicle with exclusive rights to deploy and operate the company's …

Nitish Kishor | 28 July 2026

Why Is NewGenIVF Group (NASDAQ:NIVF) Down 13% Today?

NewGenIVF Group (NASDAQ:NIVF) shares declined sharply in Tuesday trading after the company announced a follow-on investment to increase its equity stake in K25.ai, an AI-native livestreaming and information market platform, from 10 percent to 13 percent at a US$250 million valuation for the K25.ai …

Nitish Kishor | 28 July 2026

OPKO Health (NASDAQ:OPK) Extends Gains, Up 33% Today After Q2 Earnings Beat

OPKO Health (NASDAQ:OPK) shares surged further in Tuesday trading, extending sharp gains that began following Monday's second-quarter earnings release. The stock's continued advance reflects sustained investor enthusiasm for the company's narrower-than-expected quarterly loss and improved segment performance across both diagnostics and pharmaceuticals.

Nitish Kishor | 28 July 2026
Support

Hi! How can we help you today?

Loading…